NASDAQ:PINC - Premier Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $37.64
  • Forecasted Upside: 7.64 %
  • Number of Analysts: 14
  • Breakdown:
  • 2 Sell Ratings
  • 6 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$34.97
▲ +0.21 (0.60%)
1 month | 3 months | 12 months
Get New Premier Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PINC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PINC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$37.64
▲ +7.64% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Premier in the last 3 months. The average price target is $37.64, with a high forecast of $44.00 and a low forecast of $32.00. The average price target represents a 7.64% upside from the last price of $34.97.
Hold
The current consensus among 14 investment analysts is to hold stock in Premier. This rating has held steady since August 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 0 sell ratings
8/3/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
11/1/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 1 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 8 hold ratings
  • 1 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 1 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 1 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 1 sell ratings
12/25/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 2 sell ratings
1/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/19/2021Bank of AmericaDowngradeBuy ➝ Underperform$41.00 ➝ $36.00High
i
1/15/2021Credit Suisse GroupDowngradeNeutral ➝ Underperform$35.00Low
i
1/8/2021Jefferies Financial GroupDowngradeBuy ➝ Hold$40.00Low
i
1/7/2021Canaccord GenuityBoost Price TargetBuy$37.00 ➝ $44.00Low
i
12/8/2020Berenberg BankInitiated CoverageBuy$42.00Low
i
11/3/2020Piper SandlerBoost Price TargetNeutral$31.00 ➝ $32.00High
i
10/7/2020Raymond JamesReiterated RatingBuyMedium
i
8/31/2020GuggenheimUpgradeNeutral ➝ Buy$37.00Medium
i
8/27/2020UBS GroupLower Price TargetNeutral$33.00 ➝ $32.00Low
i
8/26/2020SVB LeerinkLower Price TargetOutperform$42.00 ➝ $39.00Medium
i
Rating by S. Demko at SVB Leerink LLC
8/26/2020Raymond JamesLower Price TargetOutperform$40.00 ➝ $37.00Medium
i
8/26/2020BenchmarkDowngradeBuy ➝ HoldMedium
i
8/12/2020Credit Suisse GroupLower Price TargetNeutral$37.00 ➝ $35.00High
i
5/12/2020SunTrust BanksBoost Price TargetHold$30.00 ➝ $32.00Medium
i
5/11/2020Cantor FitzgeraldInitiated CoverageOverweight$42.00Medium
i
5/6/2020Robert W. BairdBoost Price TargetNeutral$34.00 ➝ $36.00Low
i
5/6/2020UBS GroupLower Price TargetNeutral$35.00 ➝ $33.00Medium
i
4/13/2020SVB LeerinkInitiated CoverageOutperform$42.00High
i
Rating by S. Demko at SVB Leerink LLC
3/26/2020SunTrust BanksLower Price TargetHold$38.00 ➝ $30.00High
i
2/11/2020Credit Suisse GroupLower Price TargetNeutral$38.00 ➝ $37.00Low
i
2/5/2020Robert W. BairdLower Price TargetNeutral$41.00 ➝ $36.00Medium
i
Rating by Eric Coldwell at Robert W. Baird
2/5/2020BenchmarkReiterated RatingBuy$46.00 ➝ $43.00Medium
i
2/4/2020Piper SandlerReiterated RatingHoldMedium
i
Rating by Sean Wieland at Piper Sandler
1/19/2020BarclaysReiterated RatingBuy$44.00Low
i
11/11/2019Robert W. BairdDowngradeOutperform ➝ Neutral$41.00Low
i
Rating by Eric Coldwell at Robert W. Baird
11/11/2019Evercore ISIReiterated RatingHoldLow
i
10/31/2019UBS GroupDowngradeBuy ➝ Neutral$44.00 ➝ $38.00High
i
10/15/2019Canaccord GenuityUpgradeHold ➝ Buy$36.00High
i
Rating by Richard Close at Canaccord Genuity
9/26/2019Jefferies Financial GroupSet Price TargetBuy$43.00Low
i
Rating by Jason Plagman at Jefferies Financial Group Inc.
9/26/2019Robert W. BairdSet Price TargetBuy$46.00Low
i
Rating by Eric Coldwell at Robert W. Baird
8/22/2019Piper Jaffray CompaniesReiterated RatingHoldHigh
i
Rating by Sean Wieland at Piper Jaffray Companies
8/21/2019Canaccord GenuitySet Price TargetHold$36.00N/A
i
Rating by Richard Close at Canaccord Genuity
8/13/2019Credit Suisse GroupReiterated RatingOutperform ➝ Neutral$43.00 ➝ $42.00Low
i
6/18/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$41.00Low
i
5/2/2019CitigroupUpgradeNeutral ➝ Buy$45.00Medium
i
1/17/2019UBS GroupInitiated CoverageBuy ➝ Buy$45.00Low
i
9/25/2018BarclaysInitiated CoverageOverweightHigh
i
8/22/2018SVB LeerinkSet Price TargetBuy$45.00 ➝ $55.00High
i
Rating by David Larsen at SVB Leerink LLC
8/22/2018Canaccord GenuityBoost Price TargetHold ➝ Hold$38.00 ➝ $42.00High
i
8/22/2018Raymond JamesBoost Price TargetOutperform ➝ In-Line$37.00 ➝ $49.00High
i
8/22/2018BenchmarkReiterated RatingIn-Line ➝ Buy$40.00 ➝ $50.00Medium
i
8/22/2018SunTrust BanksDowngradeBuy ➝ Hold$38.00Medium
i
8/21/2018OppenheimerBoost Price TargetOutperform$48.00High
i
8/21/2018Piper Jaffray CompaniesBoost Price TargetNeutral$32.00 ➝ $40.00High
i
8/14/2018Canaccord GenuityDowngradeBuy ➝ Hold$43.00High
i
6/27/2018SVB LeerinkInitiated CoverageOutperform$45.00Low
i
Rating by D. Larsen at SVB Leerink LLC
5/9/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$42.00 ➝ $38.00Low
i
2/27/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$39.00High
i
2/13/2018CowenInitiated CoverageMarket Perform$35.00Medium
i
Rating by Charles Rhyee at Cowen Inc
2/8/2018SunTrust BanksReiterated RatingBuy$38.00High
i
2/8/2018BenchmarkInitiated CoverageBuy ➝ Buy$40.00Medium
i
2/7/2018Piper Jaffray CompaniesReiterated RatingNeutral ➝ HoldMedium
i
2/6/2018William BlairReiterated RatingOutperformMedium
i
1/18/2018Evercore ISIInitiated CoverageIn ➝ In-Line$33.50Low
i
1/4/2018CitigroupInitiated CoverageNeutralMedium
i
12/19/2017JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$30.00High
i
12/7/2017OppenheimerReiterated RatingBuy$40.00Low
i
11/17/2017SunTrust BanksLower Price TargetBuy$36.00N/A
i
11/10/2017Robert W. BairdReiterated RatingBuy$35.00N/A
i
10/4/2017KeyCorpReiterated RatingBuy$42.00Low
i
8/22/2017Piper Jaffray CompaniesReiterated RatingHoldLow
i
8/22/2017William BlairReiterated RatingOurperformLow
i
8/9/2017Jefferies Financial GroupReiterated RatingBuy$40.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
5/25/2017Bank of AmericaBoost Price TargetBuy$37.00 ➝ $39.00Low
i
5/25/2017UBS GroupReiterated RatingNeutral$34.00 ➝ $35.00N/A
i
Rating by Michael Cherny at UBS Group AG
4/13/2017Jefferies Financial GroupReiterated RatingBuy$40.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
3/28/2017Bank of AmericaUpgradeUnderperform ➝ Buy$37.00High
i
3/3/2017Evercore ISIDowngradeHold ➝ UnderperformN/A
i
2/7/2017OppenheimerSet Price TargetBuy$40.00N/A
i
Rating by Mohan Naidu at Oppenheimer Holdings Inc.
2/7/2017UBS GroupBoost Price TargetNeutral$33.00 ➝ $34.00N/A
i
Rating by Michael Cherny at UBS Group AG
2/7/2017William BlairReiterated RatingOutperformN/A
i
1/16/2017Jefferies Financial GroupSet Price TargetBuy$40.00N/A
i
Rating by sean dodge at Jefferies Financial Group Inc.
1/13/2017Canaccord GenuityReiterated RatingBuy$40.00N/A
i
12/1/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
11/29/2016UBS GroupSet Price TargetHold$32.50 ➝ $33.00N/A
i
Rating by Michael Cherny at UBS Group AG
11/7/2016Bank of AmericaDowngradeBuy ➝ Underperform$30.00N/A
i
11/4/2016Credit Suisse GroupReiterated RatingBuy$39.00N/A
i
10/28/2016JPMorgan Chase & Co.Reiterated RatingOverweightN/A
i
10/5/2016UBS GroupInitiated CoverageNeutral$32.50N/A
i
9/11/2016Canaccord GenuityReiterated RatingBuy$40.00N/A
i
Rating by Richard Close at Canaccord Genuity
8/29/2016SunTrust BanksLower Price TargetBuy$40.00 ➝ $38.00N/A
i
8/24/2016Credit Suisse GroupReiterated RatingBuy$39.00N/A
i
8/23/2016OppenheimerReiterated RatingOutperformN/A
i
Rating by Mohan Naidu at Oppenheimer Holdings Inc.
8/23/2016Canaccord GenuityReiterated RatingBuy$43.00N/A
i
Rating by Richard Close at Canaccord Genuity
8/23/2016Robert W. BairdLower Price TargetOutperform$41.00 ➝ $39.00N/A
i
8/23/2016CitigroupBoost Price TargetBuy$38.00 ➝ $40.00N/A
i
8/23/2016BarclaysLower Price TargetOverweight$41.00 ➝ $39.00N/A
i
Rating by Eric Percher at Barclays PLC
8/23/2016Evercore ISIDowngradeBuy ➝ Hold$36.50 ➝ $34.00N/A
i
8/22/2016Jefferies Financial GroupSet Price TargetBuy$40.00N/A
i
Rating by sean dodge at Jefferies Financial Group Inc.
8/5/2016Credit Suisse GroupInitiated CoverageOutperform$39.00N/A
i
6/29/2016Canaccord GenuityReiterated RatingBuy$40.00N/A
i
Rating by Richard Close at Canaccord Genuity
6/8/2016Canaccord GenuityReiterated RatingBuyN/A
i
Rating by Richard Close at Canaccord Genuity
6/1/2016BarclaysInitiated CoverageOverweight$41.00N/A
i
5/22/2016KeyCorpReiterated RatingBuyN/A
i
Rating by Donald Hooker at KeyCorp
5/10/2016Canaccord GenuityReiterated RatingBuyN/A
i
Rating by Richard Close at Canaccord Genuity
5/10/2016OppenheimerReiterated RatingBuyN/A
i
Rating by Mohan Naidu at Oppenheimer Holdings Inc.
4/11/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
2/10/2016SunTrust BanksLower Price TargetBuy$44.00 ➝ $41.00N/A
i
2/10/2016Jefferies Financial GroupReiterated RatingBuy$44.00 ➝ $40.00N/A
i
2/9/2016Piper Jaffray CompaniesLower Price TargetNeutral$38.00 ➝ $30.00N/A
i
2/9/2016Jefferies Financial GroupLower Price TargetBuy$44.00 ➝ $40.00N/A
i
2/9/2016OppenheimerReiterated RatingOutperform$41.00 ➝ $43.00N/A
i
Rating by Mohan Naidu at Oppenheimer Holdings Inc.
2/9/2016Canaccord GenuityReiterated RatingBuy$43.00 ➝ $39.00N/A
i
Rating by Richard Close at Canaccord Genuity
(Data available from 1/25/2016 forward)
Premier logo
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates through two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and document shredding services. It is also involved in the provision of the ASCEND Collaborative service for members to receive group purchasing programs, tiers, and prices, as well as managed services; SURPASS Collaborative service; STOCKD, an e-commerce platform; and PROVIDEGX program, which identifies supply sources for drugs that are on or may be at risk of being added to the national drug shortage list, or that are vulnerable to pricing volatility, as well as direct sourcing business. The Performance Services segment offers PremierConnect for members to address existing cost and quality imperatives, enable them manage a value-based care reimbursement model, and support their regulatory reporting framework; performance improvement collaborative; and consulting and insurance services. This segment's various PremierConnect domains include PremierConnect Quality & Regulatory, PremierConnect Clinical Surveillance & Safety, PremierConnect Supply Chain & ERP, PremierConnect Operations, PremierConnect Enterprise Analytics, and PREMIERCONNECT Clinical Decision Support domains. Premier, Inc. has a collaboration to develop a same-day breast cancer diagnosis and treatment model. The company was incorporated in 2013 and is headquartered in Charlotte, North Carolina.
Read More

Today's Range

Now: $34.97
$34.40
$35.24

50 Day Range

MA: $35.87
$34.14
$37.42

52 Week Range

Now: $34.97
$27.11
$37.79

Volume

276,500 shs

Average Volume

567,664 shs

Market Capitalization

$4.27 billion

P/E Ratio

N/A

Dividend Yield

2.17%

Beta

0.26

Frequently Asked Questions

What sell-side analysts currently cover shares of Premier?

The following Wall Street analysts have issued research reports on Premier in the last year: Bank of America Co., Benchmark Co., Berenberg Bank, Canaccord Genuity, Cantor Fitzgerald, Credit Suisse Group AG, Guggenheim, Jefferies Financial Group Inc., Piper Sandler, Raymond James, Robert W. Baird, SunTrust Banks, Inc., SVB Leerink LLC, TheStreet, UBS Group AG, and Zacks Investment Research.

What is the current price target for Premier?

14 Wall Street analysts have set twelve-month price targets for Premier in the last year. Their average twelve-month price target is $37.64, suggesting a possible upside of 7.6%. Canaccord Genuity has the highest price target set, predicting PINC will reach $44.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $32.00 for Premier in the next year.

What is the current consensus analyst rating for Premier?

Premier currently has 2 sell ratings, 6 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PINC, but not buy more shares or sell existing shares.

What other companies compete with Premier?

How do I contact Premier's investor relations team?

Premier's physical mailing address is 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The company's listed phone number is 704-357-0022 and its investor relations email address is [email protected] The official website for Premier is www.premierinc.com.